|
2024 Conference Publication A Randomised, Placebo-Controlled, Phase II Trial of Adjuvant Avelumab in Patients with Stage I-III Merkel Cell CarcinomaXu, Wen, Poulsen, Michael, Atkinson, Victoria, Fogarty, Gerald, Veness, Michael, Smithers, Bernard, Gyorki, David, Mar, Victoria and Guminski, Alexander (2024). A Randomised, Placebo-Controlled, Phase II Trial of Adjuvant Avelumab in Patients with Stage I-III Merkel Cell Carcinoma. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Sydney, NSW Australia, 14-16 August 2024. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14111 |
|
2024 Conference Publication A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTGLeong, T., Smithers, B.M., Michael, M., Haustermans, K.M., Wong, R., Gebski, V., O'Connell, R., Zalcberg, J.R., Boussioutas, A., Findlay, M., Willis, D., Moore, A., Lordick, F., O'Callaghan, C., Swallow, C., Darling, G.E., Strickland, A., Liberman, M., Mineur, L. and Simes, J. (2024). A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTG. ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.2300 |
|
2024 Conference Publication Alterations In Local Oesophageal Microbiota And Outcomes After Oesophagectomy For Oesophago-gastric Cancer: A Pilot StudyStokes, Matthew, (Frank) Yu, Zirong, Schlebusch, Sanmarie, Jennison, Amy, Graham, Rikki, Cooper, Caroline, Smithers, B. Mark, Barbour, Andrew, Thomson, Iain and Frankel, Adam (2024). Alterations In Local Oesophageal Microbiota And Outcomes After Oesophagectomy For Oesophago-gastric Cancer: A Pilot Study. 20th ISDE World Congress for Esophageal Diseases, Edinburgh, United Kingdom, 22 - 24 September 2024. Cary, NC United States: Oxford University Press. doi: 10.1093/dote/doae057.006 |
|
2023 Conference Publication Gastric filling in neoadjuvant chemoradiotherapy for oesophageal cancerHwang, Yang, Chen, Beini, Mai, Tao, Lee, Dominique, Thomson, Iain, Smithers, Mark and Frankel, Adam (2023). Gastric filling in neoadjuvant chemoradiotherapy for oesophageal cancer. 19th ISDE World Congress for Esophageal Diseases, Toronto, ON, Canada, 8-10 September 2023. Los Angeles, CA, United States: John Wiley & Sons. doi: 10.1093/dote/doad052.183 |
|
2023 Conference Publication Automated assessment of tumor infiltrating lymphocytes informs mortality in thin melanomaTan, S. X., Aung, T. Nwe, Claeson, M., Zhou, C., Brown, S., Acs, B., Lambie, D., Baade, P., Pandeya, N., Soyer, H., Smithers, B., Whiteman, D., Rimm, D. and Khosrotehrani, K. (2023). Automated assessment of tumor infiltrating lymphocytes informs mortality in thin melanoma. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 12 - 13 May 2023. Oxford, United Kingdom: Elsevier. |
|
2023 Conference Publication Surgery and radiotherapy can successfully salvage isolated lymph node field recurrence after lymphadenectomy in patients with melanomaHenderson, Michael A., Gyorki, David, Burmeister, Bryan, Fisher, Richard, Di Julio, Juliana, Smithers, Mark, Hong, Angela, Shannon, Kerwin, Scolyer, Richard A., Carruthers, Scott, Coventry, Brendon, Babington, Scott, Duprat, Joao, Hoekstra, Harald and Thompson, John (2023). Surgery and radiotherapy can successfully salvage isolated lymph node field recurrence after lymphadenectomy in patients with melanoma. Annual International Conference of the Society-of-Surgical-Oncology (SSO) on Surgical Cancer Care, Boston, MA United States, 22-25 March 2023. New York, NY United States: Springer. doi: 10.1245/s10434-023-13332-7 |
|
2022 Conference Publication Radiomics biomarkers are associated with survival in patients with oesophageal adenocarcinomaAoude, L.G., Bonazzi, V.F., Brosda, S., Wong, B., Moradi, H., Lonie, J., Bradford, J., Bloxham, C., Atkinson, V.G., Law, P., Lampe, G., Smithers, M., Waddell, N., Vegh, V., Miles, K. and Barbour, A.P. (2022). Radiomics biomarkers are associated with survival in patients with oesophageal adenocarcinoma. ESMO Congress 2022, Singapore, 9 - 13 September 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2022.07.1357 |
|
2022 Conference Publication Classification of esophageal adenocarcinoma into subgroups that are associated with patient survival using RNA-seq and immunohistochemistrySharma, Sowmya, Naeini, Marjan, Aoude, Lauren G., Bonazzi, Vanessa F., Gartside, Michael G., Loffler, Kelly A., Patel, Kalpana, Newell, Felicity, Lampe, Guy, Brosda, Sandra, Thomas, Janine, Smithers, Mark, Simes, John, Watson, David I., Pearson, John, Barbour, Andrew and Waddell, Nic (2022). Classification of esophageal adenocarcinoma into subgroups that are associated with patient survival using RNA-seq and immunohistochemistry. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2022 Conference Publication The association between BRAF-V600E mutations and death from thin (<=1.0 mm) melanoma: a population-based nested case-case study from Queensland, AustraliaClaeson, Magdalena, Tan, S., Brown, S., Walsh, M. D., Lambie, D., Baade, P. D., Whitehead, K. J., Soyer, H. P., Smithers, B. M., Green, A. C., Whiteman, D. C. and Khosrotehrani, K. (2022). The association between BRAF-V600E mutations and death from thin (<=1.0 mm) melanoma: a population-based nested case-case study from Queensland, Australia. 35th Nordic Congress of Dermatology and Venereology, the NCDV 2022, Copenhagen, Denmark, 19-22 April 2022. Uppsala, Sweden: Society for the Publication of Acta Dermato - Venereologica. |
|
2021 Conference Publication A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma (I-MAT Trial)Xu, W., Poulsen, M., Atkinson, V., Fogarty, G., Veness, M., Smithers, B., Gyorki, D., Mar, V., Howle, J., Guminski, A., Williams, N. and Paton, E. (2021). A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma (I-MAT Trial). HOBOKEN: WILEY. |
|
2020 Conference Publication Tracking genomic and transcriptomic features of oesophageal adenocarcinoma for improving patients outcomeNaeini, Marjan, Newell, Felicity, Aoude, Lauren G., Bonazzi, Vanessa F., Patel, Kalpana, Koufariotis, Lambros T., Johnson, Rebecca, Addala, Venkateswar, Kondrashova, Olga, Holmes, Oliver, Leonard, Conrad, Wood, Scott, Xu, Christina, Nones, Katia, Pearson, John V., Smithers, Mark, Watson, David, Simes, John, Price, Tim, Gebski, Val, Barbour, Andrew P. and Waddell, Nic (2020). Tracking genomic and transcriptomic features of oesophageal adenocarcinoma for improving patients outcome. HOBOKEN: WILEY. |
|
2020 Conference Publication A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Results in patients naive to immune checkpoint blockadeAgarwala, S. S., Ross, M., Zager, J. S., Sarnaik, A. S., Shirai, K., Lu, G., Essner, R., Smithers, B., Atkinson, V. Victoria and Wachter, E. (2020). A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Results in patients naive to immune checkpoint blockade. ESMO Virtual Congress, Electr Network, Sep 19-Oct 18, 2020. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2020.08.1248 |
|
2020 Conference Publication Patient-reported outcome (PRO) results from AGITG DOCTOR: A randomised phase II trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinomaMercieca-Bebber, R., Barnes, E. H., Wilson, K., Samoon, Z., Walpole, E. T., Mai, T., Ackland, S., Burge, M., Dickie, G., Watson, D., Leung, J., Wang, T., Bohmer, R., Cameron, D., Simes, R., Gebski, V., Smithers, M., Thomas, J., Zalcberg, J. R. and Barbour, A. (2020). Patient-reported outcome (PRO) results from AGITG DOCTOR: A randomised phase II trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma. ESMO Virtual Congress, Electr Network, Sep 19-Oct 18, 2020. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2020.08.1936 |
|
2020 Conference Publication A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Initial results in patients refractory to checkpoint blockadeZager, J. S., Sarnaik, A. S., Pilon-Thomas, S., Beatty, M., Han, D., Lu, G., Agarwala, S. S., Ross, M., Shirai, K., Essner, R., Smithers, B., Atkinson, V. Victoria and Wachter, E. (2020). A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Initial results in patients refractory to checkpoint blockade. ESMO Virtual Congress, Electr Network, Sep 19-Oct 18, 2020. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2020.08.1246 |
|
2020 Conference Publication Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and AustraliaSun, J., Kroon, H. M., Miura, J. T., Beasley, G. M., Farrow, N. E., Mosca, P., Lowe, M. C., Farley, C. R., Kim, Y., Naqvi, S. M., Carr, M. J., Kirichenko, D., Potdar, A., Daou, H., Mullen, D., Farma, J. M., Henderson, M. A., Serpell, J., Delman, K. A., Smithers, M., Coventry, B. J., Tyler, D. S., Thompson, J. F. and Zager, J. S. (2020). Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER. |
|
2020 Conference Publication The Utility of Ultrasound in the Follow-up of Patients with Melanoma Sentinel Node Metastases Undergoing Observation: An Analysis of MSLT-IIGarland-Kledzik, M., Thompson, J. F., Cochran, A. J., Hyngstrom, J., Caraco, C., Zager, J. S., Jahkola, T., Beitsch, P. D., Moncrieff, M., Ingvar, C., Levine, E., Henderson, M. A., Dummer, R., Rossi, C., Wright, F., Byrd, D., Matter, M., Ross, A. M., Hsueh, E., Johnson, D. B., Terheyden, P., Wayne, J. D., Huston, T., Smithers, M., Ariyan, C. E., Schneebaum, S., Jacobs, L. K., McMasters, K., Gesierich, A. ... Faries, M. B. (2020). The Utility of Ultrasound in the Follow-up of Patients with Melanoma Sentinel Node Metastases Undergoing Observation: An Analysis of MSLT-II. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER. |
|
2020 Conference Publication Sentinel Lymph Node Biopsy in Melanoma is Therapeutic: Predictors of Long-Term Node Basin Control with SLN Biopsy AloneCrystal, J., Thompson, J. F., Cochran, A. J., Hyngstrom, J., Caraco, C., Zager, J. S., Jahkola, T., Beitsch, P. D., Moncrieff, M., Ingvar, C., Levine, E., Agnese, D., Henderson, M. A., Dummer, R., Rossi, C., Wright, F., Byrd, D., Matter, M., Ross, A. M., Hsueh, E., Johnson, D. B., Terheyden, P., Wayne, J. D., Huston, T., Smithers, M., Ariyan, C. E., Schneebaum, S., Jacobs, L. K., McMasters, K. M. ... Faries, M. B. (2020). Sentinel Lymph Node Biopsy in Melanoma is Therapeutic: Predictors of Long-Term Node Basin Control with SLN Biopsy Alone. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER. |
|
2020 Conference Publication Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-Center AnalysisKroon, H. M., Kenyon-Smith, T., Miura, J. T., Teras, J., Beasley, G. M., Mullen, D., Farrow, N. E., Mosca, P., Lowe, M. C., Farley, C. R., Kim, Y., Naqvi, S. M., Potdar, A., Daou, H., Sun, J., Farma, J. M., Henderson, M. A., Speakman, D., Serpell, J., Delman, K. A., Smithers, M., Coventry, B. J., Tyler, D. S., Zager, J. S. and Thompson, J. F. (2020). Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-Center Analysis. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER. |
|
2020 Conference Publication Highlights of the 2019 Annual Academic Surgery ConferenceDi Bella, Claudia, Lee, James C., Koh, Cherry E., Mukherjee, Payal and Smithers, Mark (2020). Highlights of the 2019 Annual Academic Surgery Conference. 2019 Annual Academic Surgery Conference, Melbourne, VIC, Australia, 7-8 November 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ans.15713 |
|
2019 Conference Publication A randomised, double-blind, placebo-controlled, multi-institutional phase II study of adjuvant anti-PD-1 in patients with stage I-III Merkel cell carcinoma [I-MAT study]Xu, Wen, Poulsen, Michael, Atkinson, Victoria, Fogarty, Gerald, Veness, Michael, Smithers, Bernard, Gyorki, David, Mar, Victoria, Howle, Julie, Guminski, Alexander, Williams, Narelle and Paton, Elizabeth (2019). A randomised, double-blind, placebo-controlled, multi-institutional phase II study of adjuvant anti-PD-1 in patients with stage I-III Merkel cell carcinoma [I-MAT study]. HOBOKEN: WILEY. |
